These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 820172)
1. Chemical models and chemotherapy in the sphingolipidoses. Radin NS Adv Exp Med Biol; 1976; 68():453-72. PubMed ID: 820172 [No Abstract] [Full Text] [Related]
3. Sphingolipids. Stoffel W Annu Rev Biochem; 1971; 40():57-82. PubMed ID: 4941240 [No Abstract] [Full Text] [Related]
4. The association of the galactosyl diglycerides of brain with myelination. II. The inability of the myelin-deficient mutant, jimpy mouse, to synthesize galactosyl diglycerides effectively. Deshmukh DS; Inoue T; Pieringer RA J Biol Chem; 1971 Sep; 246(18):5695-9. PubMed ID: 5096090 [No Abstract] [Full Text] [Related]
5. Treating glucosphingolipid disorders by chemotherapy: use of approved drugs and over-the-counter remedies. Radin NS J Inherit Metab Dis; 2000 Dec; 23(8):767-77. PubMed ID: 11196103 [TBL] [Abstract][Full Text] [Related]
6. [Disturbances of the lipid metabolism in relation to the nervous system. II. Sphingolipids and sphingolipidoses]. Tichý J Cesk Neurol; 1973 Jan; 36(1):51-60. PubMed ID: 4685128 [No Abstract] [Full Text] [Related]
7. Cancer and sphingolipid storage disease therapy using novel synthetic analogs of sphingolipids. Gatt S; Dagan A Chem Phys Lipids; 2012 May; 165(4):462-74. PubMed ID: 22387097 [TBL] [Abstract][Full Text] [Related]
8. The biochemistry of sphingolipid storage diseases. Sandhoff K Angew Chem Int Ed Engl; 1977 May; 16(5):273-85. PubMed ID: 406814 [No Abstract] [Full Text] [Related]
9. Pathology and current treatment of neurodegenerative sphingolipidoses. Eckhardt M Neuromolecular Med; 2010 Dec; 12(4):362-82. PubMed ID: 20730629 [TBL] [Abstract][Full Text] [Related]
10. Enzyme defects in the sphingolipidoses and their application to diagnosis. Brady RO Ann Clin Lab Sci (1971); 1972; 2(4):285-94. PubMed ID: 4342099 [No Abstract] [Full Text] [Related]
11. A possible therapeutic approach to Krabbe's globoid leukodystrophy and the status of cerebroside synthesis in the disorder. Radin NS; Arora RC; Ullman MD; Brenkert AL; Austin J Res Commun Chem Pathol Pharmacol; 1972 May; 3(3):637-44. PubMed ID: 5034520 [No Abstract] [Full Text] [Related]
12. Deficiency of monogalactosyl diglycerid beta-B-galactosidase activity in krabbe's disease. Wenger DA; Satter M; Markey JP Biochem Biophys Res Commun; 1973 Jul; 53(2):680-5. PubMed ID: 4716994 [No Abstract] [Full Text] [Related]
13. Localized beta-galactosidase deficiency. Occurrence in cerebellar ataxia with myoclonus epilepsy and macular cherry-red spot--a new variant of GM1-gangliosidosis? Yamamoto A; Adachi S; Kawamura S; Takahashi M; Kitani T Arch Intern Med; 1974 Oct; 134(4):627-34. PubMed ID: 4278184 [No Abstract] [Full Text] [Related]
14. Enzyme replacement therapy for the sphingolipidoses. Brady RO; Pentchev PG; Gal AE; Hibbert SR; Quirk JM; Mook GE; Kusiak JW; Tallman JF; Dekaban AS Adv Exp Med Biol; 1976; 68():523-32. PubMed ID: 820173 [No Abstract] [Full Text] [Related]
15. Sphingolipidoses and allied disorders. Crocker AC Adv Exp Med Biol; 1976; 68():585-9. PubMed ID: 132847 [No Abstract] [Full Text] [Related]